Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adoptive Immunotherapy with gd T Cells, IL-2, and Zoledronic Acid for Stage IV RCC
NCT00588913Phase 2Completed
- Sponsor
- Tokyo Women's Medical University
- Start
- Jan 2006
- Primary completion
- Mar 2009
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of Vγ9Vδ2 T cells in renal cell carcinoma (RCC), sponsored by Tokyo Women's Medical University. Started Jan 2006; status: completed.
02
Drugs
Vγ9Vδ2 T cells
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00588913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00588913.